Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
作者: S. FuH. HirteS. WelchT. T. IlenchukT. LutesC. RiceN. FieldsA. NemetD. DugourdS. Piha-PaulV. SubbiahL. LiuJ. GongD. HongJ. M. Stewart
作者单位: 1Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center
2Juravinski Cancer Centre
3London Health Sciences Centre
4Soricimed Biopharma Inc.
5Sagecon Inc.
6CLINSIG Research Consulting Inc.
刊名: Investigational New Drugs, 2017, Vol.35 (3), pp.397-397
来源数据库: Springer Journal
DOI: 10.1007/s10637-017-0455-y
全文获取路径: Springer  (合作)
影响因子:3.498 (2012)

  • 槽水道 人的
  • inhibitor 抑制剂
  • calcium 
  • SOR Serial Output Register
  • human 人的
  • channel 人的
  • phase 相位
  • solid 固体
  • study 学习
  • advanced 先进的